Welcome to DLRC

Ian is a Principal Regulatory Consultant at DLRC. He is a Fellow of the Royal Pharmaceutical Society with a PhD in Pharmaceutics. Ian has worked in pharmaceutical development for 17 years, CMC technical leadership for 14 years, as a MHRA quality assessor for three years and for 6 years at DLRC. He has developed and assessed many inhaled products. His experience as a medicine developer, regulator and consultant, gives him a unique perspective and can develop successful strategies for clients. Ian worked on the last propellant transition from CFC to HFA propellants and is now helping DLRC's clients with their inhaled products.

Catherine is a Principal Regulatory Consultant at DLRC, specialising in Chemistry, Manufacturing and Controls (CMC). Catherine has a B.Sc. in Chemistry and worked in radiosynthesis and analytical development before moving into Regulatory Affairs in the generics field 20 years ago, where she had her first taste of inhaled drug product registration. Catherine works with a range of clients at DLRC, advising on regulatory and CMC development strategy, authoring submissions and managing health authority interactions. She covers small molecules, biologics, ATMP, drug-device combinations and others across the product lifecycle. She has supported several inhaled product developments and brings a broad oversight of CMC regulatory and cGMP requirements.

Claire’s role involves shaping the company's commercial strategy and leading the business development team. Claire has many years of Industry experience and a track record of success building teams that are laser-focused on delivering for clients and creating lasting value in partnerships. Having worked with GSK and AstraZeneca and global and niche CROs, she is well-placed to support DLRC's new clients in their journey to navigate the increasing complexities of the regulatory landscape successfully. Claire obtained a bachelor’s in nursing and began her pharmaceutical career in clinical project management. She then studied for an MPhil in translational medicine & therapeutics at the University of Cambridge.